Kezar Life Sciences, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 22.2 million compared to USD 16.02 million a year ago. Basic loss per share from continuing operations was USD 0.31 compared to USD 0.26 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6825 USD | -1.69% | -0.32% | -27.96% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.96% | 49.69M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- KZR Stock
- News Kezar Life Sciences, Inc.
- Kezar Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023